US 7429387
Use of botulinum toxin therapy for treatment of recalcitrant voiding dysfunction
granted A61KA61K31/165A61K31/529
Quick answer
US patent 7429387 (Use of botulinum toxin therapy for treatment of recalcitrant voiding dysfunction) held by The Regents of the University of Colorado expires Mon Sep 25 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of Colorado
- Grant date
- Tue Sep 30 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 25 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K31/165, A61K31/529, A61K38/1703, A61K38/4893